SSC clinical trials at University of California Health
1 in progress, 0 open to eligible people
Showing trials for
Non-comparative Study of IFX-1 Alone or IFX-1+Pembrolizumab in Patients With Locally Advanced or Metastatic cSCC.
Sorry, in progress, not accepting new patients
This is an open-label, "non comparative", non-randomized, Phase II study. Patients will be enrolled in 2 treatment arms